Zacks: Brokerages Anticipate Colgate-Palmolive (CL) Will Announce Earnings of $0.73 Per Share

Wall Street analysts predict that Colgate-Palmolive (NYSE:CL) will post earnings per share (EPS) of $0.73 for the current quarter, according to Zacks. Eight analysts have issued estimates for Colgate-Palmolive’s earnings. The lowest EPS estimate is $0.70 and the highest is $0.76. Colgate-Palmolive reported earnings of $0.67 per share in the same quarter last year, which would indicate a positive year over year growth rate of 9%. The company is scheduled to announce its next earnings results before the market opens on Friday, April 27th.

On average, analysts expect that Colgate-Palmolive will report full-year earnings of $3.18 per share for the current financial year, with EPS estimates ranging from $3.15 to $3.21. For the next fiscal year, analysts expect that the company will report earnings of $3.44 per share, with EPS estimates ranging from $3.39 to $3.52. Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that that provide coverage for Colgate-Palmolive.

How to Become a New Pot Stock Millionaire

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.75. The business had revenue of $3.89 billion for the quarter, compared to analyst estimates of $3.92 billion. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the firm posted $0.75 earnings per share.

A number of equities analysts recently weighed in on the stock. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $84.00 price objective on the stock in a research report on Monday, January 8th. Macquarie upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective on the stock in a research report on Tuesday, December 19th. BNP Paribas lowered shares of Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research report on Tuesday, January 30th. Citigroup lifted their price objective on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the company a “neutral” rating in a research report on Tuesday, January 30th. Finally, Jefferies Group reiterated a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research report on Friday, January 26th. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $77.76.

Shares of CL opened at $71.60 on Friday. The company has a debt-to-equity ratio of 27.02, a quick ratio of 1.00 and a current ratio of 1.36. The company has a market cap of $62,095.68, a PE ratio of 24.95, a price-to-earnings-growth ratio of 2.63 and a beta of 0.74. Colgate-Palmolive has a 12-month low of $67.86 and a 12-month high of $77.91.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 15th. Shareholders of record on Friday, April 20th will be issued a $0.42 dividend. The ex-dividend date is Thursday, April 19th. This represents a $1.68 dividend on an annualized basis and a yield of 2.35%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.40. Colgate-Palmolive’s dividend payout ratio (DPR) is 55.75%.

In other Colgate-Palmolive news, CTO Patricia Verduin sold 1,572 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $70.17, for a total value of $110,307.24. Following the completion of the sale, the chief technology officer now owns 50,675 shares of the company’s stock, valued at $3,555,864.75. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Ellen M. Hancock sold 4,676 shares of the firm’s stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $74.12, for a total value of $346,585.12. Following the completion of the sale, the director now directly owns 208,063 shares of the company’s stock, valued at approximately $15,421,629.56. The disclosure for this sale can be found here. In the last three months, insiders sold 454,805 shares of company stock valued at $32,375,038. 1.02% of the stock is owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. raised its stake in shares of Colgate-Palmolive by 1.4% during the 4th quarter. BlackRock Inc. now owns 52,360,691 shares of the company’s stock worth $3,950,614,000 after buying an additional 711,972 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Colgate-Palmolive by 2.1% during the 4th quarter. Geode Capital Management LLC now owns 8,975,479 shares of the company’s stock worth $675,751,000 after buying an additional 188,455 shares during the last quarter. First Eagle Investment Management LLC raised its stake in shares of Colgate-Palmolive by 35.8% during the 3rd quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock worth $483,837,000 after buying an additional 1,750,417 shares during the last quarter. OppenheimerFunds Inc. raised its stake in shares of Colgate-Palmolive by 2.8% during the 4th quarter. OppenheimerFunds Inc. now owns 6,173,804 shares of the company’s stock worth $465,813,000 after buying an additional 166,537 shares during the last quarter. Finally, APG Asset Management N.V. raised its stake in shares of Colgate-Palmolive by 33.2% during the 4th quarter. APG Asset Management N.V. now owns 5,421,184 shares of the company’s stock worth $340,630,000 after buying an additional 1,350,400 shares during the last quarter. 73.67% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: This story was originally posted by Week Herald and is owned by of Week Herald. If you are accessing this story on another site, it was stolen and republished in violation of U.S. & international copyright legislation. The legal version of this story can be read at https://weekherald.com/2018/04/15/zacks-brokerages-anticipate-colgate-palmolive-cl-will-announce-earnings-of-0-73-per-share.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply